As previously reported for CRLF2 expression in BCP-ALL, [19] in order to define CRLF2 high-expressing (“CRLF2-high”) patients, the CIR hazard ratio was calculated for each unit increase in the CRLF2 expression expressed as fold change with respect to the median value. Here, CRLF2 is linked to acute lymphoblastic leukemia.